NO168041B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RETINIC ACID ESTERS OF ERYTROMYCIN. - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RETINIC ACID ESTERS OF ERYTROMYCIN. Download PDF

Info

Publication number
NO168041B
NO168041B NO871870A NO871870A NO168041B NO 168041 B NO168041 B NO 168041B NO 871870 A NO871870 A NO 871870A NO 871870 A NO871870 A NO 871870A NO 168041 B NO168041 B NO 168041B
Authority
NO
Norway
Prior art keywords
lid
erytromycin
preparation
acid esters
therapeutic active
Prior art date
Application number
NO871870A
Other languages
Norwegian (no)
Other versions
NO871870D0 (en
NO871870L (en
NO168041C (en
Inventor
Michel Philippe
Henri Sebag
Didier Dupuis
Andre Rougier
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of NO871870D0 publication Critical patent/NO871870D0/en
Publication of NO871870L publication Critical patent/NO871870L/en
Priority to NO910442A priority Critical patent/NO168647C/en
Publication of NO168041B publication Critical patent/NO168041B/en
Publication of NO168041C publication Critical patent/NO168041C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/14Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C07H15/16Lincomycin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Description

Flercellet akkumulatorbatteri. Multi-cell accumulator battery.

Foreliggende oppfinnelse angår akkumulatorbatterier The present invention relates to accumulator batteries

av den type hvor flere celler er anordnet i en beholder, såkalte monoblokkbatterier. Et eksempel på slike batterier er startbatte-rier for biler. of the type where several cells are arranged in a container, so-called monobloc batteries. An example of such batteries are starter batteries for cars.

Oppfinnelsen angår nærmere bestemt den type av monoblokkbatterier hvor elektriske forbindelser mellom ved siden av hverandre liggende celler er anordnet som gjennomføringer i skilleveggen mellom dem. The invention specifically relates to the type of monobloc batteries where electrical connections between adjacent cells are arranged as penetrations in the partition between them.

Batteriet ifolge oppfinnelsen består av flere ved siden av hverandre i samme beholder anordnede, fortrinnsvis med felles lokk tildekkede celler som skilles fra hverandre ved isolerende væsketette vegger, hvori er anordnet elektrisk ledende forbindelser, så som gjennomføring fra en celle til en inntil liggende celle, og oppfinnelsen utmerker seg ved at skilleveggdeler omfat- The battery according to the invention consists of several cells arranged next to each other in the same container, preferably covered with a common lid, which are separated from each other by insulating liquid-tight walls, in which electrically conductive connections are arranged, such as a passage from one cell to an adjacent cell, and the invention is distinguished by the fact that partition parts include

tende nevnte gjennomføringer er anordnet i lokket. Tend said penetrations are arranged in the lid.

Det er ut fra flere synspunkter fordelaktig å fore de elektrisk ledende organer som forbinder elektrodesett i inntil hverandre anbrakte celler med hverandre, gjennom skilleveggen mellom nevnte celler. Det oppnås, som det lett vil innsees, be-tydelige materialbesparelser sammenlignet med den hittil vanlig brukte anordning av nevnte forbindelser utenpå batterilokkene. From several points of view, it is advantageous to line the electrically conductive bodies which connect electrode sets in adjacent cells to each other, through the partition between said cells. Significant material savings are achieved, as will be easily seen, compared to the previously commonly used arrangement of said connections on the outside of the battery lids.

En annen fordel består i at batteriet får en glatt over-side som med unntagelse av tilkoblingspolene savner ytre elektrisk ledende metalldeler. Another advantage is that the battery has a smooth upper side which, with the exception of the connection poles, lacks external electrically conductive metal parts.

Flere konstruksjoner er kjent, hvor ovennevnte fordeler er oppnådd på den angitte måte, imidlertid har det derved vist seg at for eller senere er der oppstått lekkasjer og.manglende tetthet for den i cellene foreliggende elektrolyt ved festepunktene for de nevnte elektrisk ledende gjennomforinger. Several constructions are known, where the above-mentioned advantages are achieved in the manner indicated, however, it has thereby been shown that sooner or later there have been leaks and a lack of tightness for the electrolyte present in the cells at the attachment points for the aforementioned electrically conductive bushings.

Vanskelighetene har sin årsak i at de ledende forbindelser fra en celle til den tilliggende celle må anbringes etter at cellens elektroder og separatorer er kommet på plass. Ved sam-mensetningen av akkumulatorer legges negative og positive elektroder sammen og loddes til sine respektive polbroer for innset-ning i cellebeholderne. Elektrodene skilles ved hjelp av elektrisk isolerende gjennomtrengelige separatorer eller skillevegger. Elektroder med samme polaritet loddes ved spesielle tilkoblingspunkter til såkalte polbroer og danner såkalte platesett. Platesettene The reason for the difficulties lies in the fact that the conductive connections from one cell to the adjacent cell must be placed after the cell's electrodes and separators have been put in place. During the assembly of accumulators, negative and positive electrodes are put together and soldered to their respective pole bridges for insertion in the cell containers. The electrodes are separated by means of electrically insulating permeable separators or partitions. Electrodes with the same polarity are soldered at special connection points to so-called pole bridges and form so-called plate sets. The plate sets

fyller ut cellene fullstendig for at elektrodene skal stå stott fills the cells completely so that the electrodes will stand

og ikke skades ved vibrasjoner og lignende. Dette innebærer imidlertid at i skilleveggene mellom cellene må der ikke være anbrakt noen gjennomforingsanordninger for platesettene er innfort i cellene. and not be damaged by vibrations and the like. This means, however, that in the partitions between the cells there must not be any feed-through devices for the plate sets to be inserted into the cells.

Ved hjelp av oppfinnelsen overvinnes disse og andre van-skeligheter som foreligger ved fremstillingen av akkumulatorer av angjeldende type på en effektiv og enkel måte ved at gjennomfbrin-gene er anordnet i de skilleveggpartier som er anordnet i behol-derlokkene. With the help of the invention, these and other difficulties which exist in the production of accumulators of the type in question are overcome in an efficient and simple way by the through-holes being arranged in the partition sections which are arranged in the container lids.

Oppfinnelsen skal i det folgende beskrives nærmere under henvisning til tegningene, hvor fig. 1 viser et akkumulatorbatteri i likhet med oppfinnelsen i delvis lengdesnitt, fig. 2 viser et delvis tverrsnitt, fig. 3 er et planriss ai samme og fig. 4 er et perspektivisk oppriss av et akkumulatorbatteri i samsvar med oppfinnelsen med en for illustrasjon avtatt dekkplate. The invention will be described in more detail below with reference to the drawings, where fig. 1 shows an accumulator battery similar to the invention in partial longitudinal section, fig. 2 shows a partial cross-section, fig. 3 is a plan view of the same and fig. 4 is a perspective elevation of an accumulator battery in accordance with the invention with a cover plate removed for illustration.

Akkumulatorbatteriet består av beholderen 1 som er delt opp i flere celler ved hjelp av skilleveggene 2 og tilhørende lokk 3. Skilleveggene 4,.er anbrakt i lokket 3 i samsvar med skilleveggene 2 i beholderen 1. Elektrisk ledende gjennomforinger 5 er væsketett f byd inn i mellom veggene 4 i lokket 3, fortrinnsvis på en slik måte at ved fremstillingen av lokket blir gjennomforingene stopt eller presset inn og anbringes i presse- henholdsvis stope-formen for lokket. Elektroder med en bestemt polaritet er for inn-setningen i beholderen 1 fortrinnsvis ved lodding, forbundet med polbroen 7. Polbroene 7 forbindes med gjennomfbringen 5 etter at lokket 3 er kommet på plass på beholderen. Forbindelsen skjer for eksempel ved motstandssveising gjennom åpningene 8 i lokket 3, hvilke åpninger deretter lukkes ved hjelp av dekkplater 9. Separatorer eller skillevegger 10 holder elektrodene 11 og 6 isolert fra hverandre* Tilkoblingspolene 12 og 13 muliggjør tilkobling til en ytre strbmkrets, en tetningsanordning 14 dekker inspeksjons- og påfyllingsåpningene 15 for påfylling av elektrolyt. Sammensetning av lokk og beholder ved 16 skjer fortrinnsvis ved hjelp av såkalt speilsveising, men kan selvfølgelig også skje ved hjelp av klebing eller sveising ved hjelp av for eksempel varme tråd. Sammenføynin-gen av polbroene 7 med gjennomfbringen 5 i forbindelsesstedene 17 skjer fortrinnsvis ved hjelp av elektrisk motstandssveising ved hjelp av hertil egnet utformede sveisetenger eller lignende gjennom åpningene 8. Dekkplatene 9 festes på plass etter at sveisingen' av polbroene 7 til gjennomfbringen 5 er utfort. The storage battery consists of the container 1, which is divided into several cells by means of the partitions 2 and associated lid 3. The partitions 4, are placed in the lid 3 in accordance with the partitions 2 in the container 1. Electrically conductive bushings 5 are liquid-tight f bid into between the walls 4 of the lid 3, preferably in such a way that during the production of the lid, the bushings are stopped or pressed in and placed in the press or stope form for the lid. Electrodes with a certain polarity are, for the insertion in the container 1, preferably by soldering, connected to the pole bridge 7. The pole bridges 7 are connected to the through-hole 5 after the lid 3 has been placed on the container. The connection takes place, for example, by resistance welding through the openings 8 in the lid 3, which openings are then closed using cover plates 9. Separators or partitions 10 keep the electrodes 11 and 6 isolated from each other* The connection poles 12 and 13 enable connection to an external power circuit, a sealing device 14 covers the inspection and filling openings 15 for filling with electrolyte. Assembly of lid and container at 16 is preferably done using so-called mirror welding, but can of course also be done using gluing or welding using, for example, hot wire. The joining of the pole bridges 7 with the lead-through 5 in the connection points 17 preferably takes place by means of electric resistance welding with the help of suitably designed welding tongs or the like through the openings 8. The cover plates 9 are fixed in place after the welding of the pole bridges 7 to the lead-through 5 has been carried out.

Ovenstående beskrivelse og vedlagte tegninger gjelder for et rent utfort eksempel på oppfinnelsen og må ikke ansees som begrensende av samme.. The above description and attached drawings apply to a purely developed example of the invention and must not be regarded as limiting the same.

Claims (2)

1. Flercellet akkumulatorbatteri omfattende flere ved siden av hverandre i samme beholder (1) anordnede, fortrinnsvis med felles lokk (3) tildekkede celler som skilles fra hverandre ved isolerende væsketette vegger (2), hvori er anordnet elektrisk ledende forbindelser (5), så som gjennomfbring fra den ene celle til den annen, karakterisert ved at skilleveggdeler (4) omfattende nevnte gjennomfbringer er anordnet i lokket.1. Multi-cell accumulator battery comprising several cells arranged next to each other in the same container (1), preferably covered with a common lid (3) and separated from each other by insulating liquid-tight walls (2), in which electrically conductive connections (5) are arranged, so as a lead-through from one cell to the other, characterized in that partition parts (4) comprising said lead-throughs are arranged in the lid. 2. Batteri ifblge krav 1, karakterisert ved at lokket (3) er forsynt med åpninger (8), gjennom hvilke sammenføy-ning av polbroer (7) med gjennomføring (5) muliggjøres. Anførte publikasjoner:2. Battery according to claim 1, characterized in that the lid (3) is provided with openings (8), through which the joining of pole bridges (7) with penetration (5) is made possible. Cited publications:
NO871870A 1986-05-06 1987-05-05 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RETINIC ACID ESTERS OF ERYTROMYCIN. NO168041C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO910442A NO168647C (en) 1986-05-06 1991-02-05 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RETINIC ACID ESTERS OF LINCOMYCIN AND CLINDAMYCIN.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8606528A FR2598420B1 (en) 1986-05-06 1986-05-06 NOVEL RETINOIC ANTIBIOTICS ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

Publications (4)

Publication Number Publication Date
NO871870D0 NO871870D0 (en) 1987-05-05
NO871870L NO871870L (en) 1987-11-09
NO168041B true NO168041B (en) 1991-09-30
NO168041C NO168041C (en) 1992-01-08

Family

ID=9334966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871870A NO168041C (en) 1986-05-06 1987-05-05 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RETINIC ACID ESTERS OF ERYTROMYCIN.

Country Status (13)

Country Link
JP (1) JP2504990B2 (en)
BE (1) BE1004152A4 (en)
CA (1) CA1300131C (en)
CH (1) CH674847A5 (en)
DE (1) DE3714937C2 (en)
DK (1) DK169345B1 (en)
ES (1) ES2006478A6 (en)
FR (1) FR2598420B1 (en)
GB (1) GB2191483B (en)
IT (1) IT1204556B (en)
NL (1) NL193946C (en)
NO (1) NO168041C (en)
SE (1) SE470379B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87041A1 (en) * 1987-11-04 1989-06-14 Oreal RETINOIC ESTERS OF MACROLIDES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87037A1 (en) * 1987-11-04 1989-06-14 Oreal POLYAROMATIC ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87035A1 (en) * 1987-11-04 1989-06-14 Oreal ETRETINIC OR APPARENT TYPE ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87038A1 (en) * 1987-11-04 1989-06-14 Oreal AROMATIC ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87036A1 (en) * 1987-11-04 1989-06-14 Oreal UNSATURATED CYCLOALIPHATIC ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87040A1 (en) * 1987-11-04 1989-06-14 Oreal POLYCYCLIC AROMATIC ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87039A1 (en) * 1987-11-04 1989-06-14 Oreal BIAROMATIC ESTERS OF MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
LU87070A1 (en) * 1987-12-10 1989-07-07 Oreal COMBINATION OF PYRIMIDINE DERIVATIVES AND AGENTS FOR INDUCING AND STIMULATING HAIR GROWTH AND REDUCING FALLING
FR2644460A1 (en) * 1989-03-16 1990-09-21 Oreal RETINOIC ESTERS OF D-DESOSAMINE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
GB2282596B (en) * 1993-10-06 1998-04-15 Ciba Geigy Ag Water-soluble retinoids
FR2931662B1 (en) * 2008-05-30 2010-07-30 Galderma Res & Dev NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE.
FR2931661B1 (en) * 2008-05-30 2010-07-30 Galderma Res & Dev NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE AND A RETINOID.
US9907812B2 (en) * 2011-06-22 2018-03-06 Vyome Biosciences Pvt. Ltd. Conjugate-based antifungal and antibacterial prodrugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862921A (en) * 1953-08-13 1958-12-02 Upjohn Co Erythromycin esters
US3598806A (en) * 1969-04-15 1971-08-10 Upjohn Co Process for preparing lincomycin-3-monoacylates
FR2378523A1 (en) * 1977-01-26 1978-08-25 Grupper Charles ACNE TREATMENT MEDICINE
FR2582000B1 (en) * 1985-05-14 1987-06-26 Oreal BI OR TRI-ENIC FATTY ESTERS OF ERYTHROMYCIN A, THEIR PREPARATION PROCESS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
DK169345B1 (en) 1994-10-10
NL193946C (en) 2001-03-02
BE1004152A4 (en) 1992-10-06
DE3714937A1 (en) 1987-11-12
JP2504990B2 (en) 1996-06-05
NL8701054A (en) 1987-12-01
JPS62289593A (en) 1987-12-16
FR2598420A1 (en) 1987-11-13
DK229387A (en) 1987-11-07
ES2006478A6 (en) 1989-05-01
NO871870D0 (en) 1987-05-05
DE3714937C2 (en) 1998-02-26
GB2191483B (en) 1990-05-30
SE470379B (en) 1994-02-07
IT1204556B (en) 1989-03-10
NO871870L (en) 1987-11-09
NL193946B (en) 2000-11-01
GB8710673D0 (en) 1987-06-10
SE8701845D0 (en) 1987-05-05
IT8720389A0 (en) 1987-05-05
SE8701845L (en) 1987-11-07
CA1300131C (en) 1992-05-05
GB2191483A (en) 1987-12-16
NO168041C (en) 1992-01-08
CH674847A5 (en) 1990-07-31
DK229387D0 (en) 1987-05-05
FR2598420B1 (en) 1991-06-07

Similar Documents

Publication Publication Date Title
NO168041B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RETINIC ACID ESTERS OF ERYTROMYCIN.
KR890004586B1 (en) Battery
EP0789411B1 (en) Sealed storage battery
DE3685822D1 (en) BATTERY.
US3141795A (en) Storage batteries
JPS62268054A (en) Storage battery
KR830009659A (en) Lead-acid batteries and manufacturing method
US8043746B2 (en) Electrical connection for a storage cell
DE59800368D1 (en) Rechargeable lithium-ion cell
US6335110B1 (en) Secondary battery
US3801376A (en) Auxiliary electrolyte system
GB2176929A (en) Galvanic cells
US3484299A (en) Multicell storage battery
JPS6040146B2 (en) laminated battery
JPS61253773A (en) Bipolar storage battery
US4458411A (en) Method of fabricating an extremely high rate flat cell
JP2003508878A (en) Low profile front terminal lead storage battery
CN109524610A (en) A kind of non-maintaining valve-regulated sealed lead-acid batteries and its corrosion-resistant cathode confluence component
US1372950A (en) Battery
GB2158285A (en) Multicell electric storage batteries
WO2018199438A1 (en) Secondary battery
US4188461A (en) Lead-acid batteries
US4356240A (en) Extremely high rate flat cell
JPH09180701A (en) Storage battery
EP0406466B1 (en) Storage battery